Fentanyl 75mcg/hr Patch

Manufacturer MYLAN Active Ingredient Fentanyl Transdermal Patch(FEN ta nil) Pronunciation FEN-ta-nil
WARNING: This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing. Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.Avoid hot baths, sunbathing, and use of heat sources (including tanning beds, heating pads, and hot tubs). Avoid activities like heavy exercise. Tell your doctor if you get a fever. A rise in body temperature may cause too much drug to pass into your body. This can cause overdose and deadly breathing problems.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life- threatening if not treated. @ COMMON USES: It is used to manage pain.This drug is not for mild pain or pain that only lasts a short time (like headaches, toothaches, or pain after surgery).This drug is only for use by people who have been taking pain drugs (opioids) and are used to their effects. Talk with the doctor.
đŸˇī¸
Drug Class
Opioid Analgesic
đŸ§Ŧ
Pharmacologic Class
Opioid Agonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Aug 1990
âš–ī¸
DEA Schedule
Schedule II

Overview

â„šī¸

What is this medicine?

Fentanyl is a very strong pain medicine that comes as a patch you stick on your skin. It's used for severe, ongoing pain in people who are already used to taking strong opioid pain medicines. The patch slowly releases the medicine into your body over 3 days to help control your pain. It's very important to use this patch exactly as prescribed because it can be dangerous if not used correctly.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication safely and effectively, follow your doctor's instructions carefully. Read all the information provided to you and follow the instructions closely.

Handling and Applying the Patch

1. Wash your hands before and after handling the patch.
2. Touch the sticky side of the patch as little as possible to avoid exposing yourself to the medication.
3. Remove the old patch before applying a new one.
4. Apply the patch to clean, dry, healthy skin on your chest, back, upper leg, or upper arm.
5. Choose a new area for the patch each time you change it.
6. If there is hair where you plan to apply the patch, clip it close to the skin. Do not shave the area.
7. Avoid applying the patch to skin that has been treated with creams, oils, lotions, or other skin products.
8. Do not apply the patch to the belt line, bra line, or skin folds.
9. You do not need to apply the patch directly to the area where you are experiencing pain for it to be effective.

Caring for the Patch

1. You can bathe, shower, or swim for short periods while wearing the patch. To keep it in place, cover it with plastic wrap and tape.
2. If the patch falls off, apply a new one.
3. If the patch is not sticking well, you can use first aid tape on the edges to hold it in place. Alternatively, you can use a see-through film dressing (such as Bioclusive or Askina Derm) over the patch. Be sure to use the correct type of dressing.
4. Do not cover the patch with any other bandage or tape.

Important Safety Precautions

1. Do not cut or divide the patches.
2. Do not use damaged patches.
3. Avoid touching the area where the patch was applied to someone else's skin. If this happens, remove the patch immediately and wash the area with water. Seek medical help right away.
4. Misusing or abusing this medication by placing it in the mouth, chewing, swallowing, injecting, or snorting it can lead to overdose and death.

Storage and Disposal

1. Store the medication at room temperature in a dry place, away from the bathroom.
2. After removing a used patch, fold the sticky sides together and dispose of it in a secure location where children and pets cannot access it.

Missing a Dose

If you miss a dose, apply a new patch as soon as you remember, after removing the old one. Do not apply a double dose or extra doses.
💡

Lifestyle & Tips

  • Avoid exposing the patch to direct heat (e.g., heating pads, electric blankets, hot tubs, saunas, prolonged sun exposure) as this can cause too much medicine to be absorbed, leading to overdose.
  • Do not cut, chew, or swallow the patch.
  • Do not use alcohol or other sedatives while on this medication.
  • Store patches securely away from children and pets. Dispose of used patches by folding the adhesive sides together and flushing down the toilet or placing in a secure disposal container.
  • Avoid driving or operating heavy machinery until you know how this medication affects you, as it can cause drowsiness and dizziness.
  • Maintain regular bowel movements to prevent constipation, a common side effect (e.g., increase fiber, fluids, consider laxatives as advised by doctor).

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial dose for opioid-tolerant patients: Convert from previous opioid to an equivalent fentanyl transdermal dose. Common initial doses range from 12 mcg/hr to 25 mcg/hr. The 75 mcg/hr patch is a higher dose typically used for patients already on high doses of other opioids or who have titrated up.
Dose Range: 12 - 100 mg

Condition-Specific Dosing:

opioid_tolerant_conversion: Use an equianalgesic conversion table. Apply patch every 72 hours. Do not use in opioid-naive patients.
titration: Dose may be adjusted every 3 days after initial application, or every 6 days thereafter, in increments of 12 mcg/hr or 25 mcg/hr, based on analgesic response and tolerability.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established. Contraindicated due to risk of fatal respiratory depression.
Infant: Not established. Contraindicated due to risk of fatal respiratory depression.
Child: Not established for children under 2 years of age. For children 2 years and older, only for opioid-tolerant patients with chronic severe pain, and only if the child weighs at least 30 kg. Dosing must be carefully individualized based on prior opioid use and conversion tables. Initial dose typically 12 mcg/hr.
Adolescent: Similar to adult dosing for opioid-tolerant adolescents, with careful consideration of weight and prior opioid exposure.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution. Monitor closely for signs of opioid toxicity.
Moderate: Use with caution. Consider dose reduction and close monitoring. Fentanyl metabolites may accumulate.
Severe: Not recommended. Significant accumulation of fentanyl and its metabolites may occur, leading to prolonged respiratory depression. If unavoidable, use with extreme caution and significant dose reduction.
Dialysis: Fentanyl is not significantly dialyzable. Use with extreme caution, as accumulation may occur.

Hepatic Impairment:

Mild: Use with caution. Monitor closely for signs of opioid toxicity.
Moderate: Use with caution. Consider dose reduction and close monitoring. Fentanyl clearance may be reduced.
Severe: Not recommended. Significant reduction in fentanyl clearance may occur, leading to prolonged and increased opioid effects. If unavoidable, use with extreme caution and significant dose reduction.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Fentanyl is a potent, synthetic opioid analgesic that primarily acts as an agonist at the mu-opioid receptors in the central nervous system (CNS). Its analgesic effects are mediated through binding to these receptors, leading to inhibition of pain pathways, altered perception of pain, and depression of the respiratory center.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 92% (transdermal, relative to IV)
Tmax: 24-72 hours (initial application), 20-27 hours (after subsequent applications)
FoodEffect: Not applicable for transdermal patch.

Distribution:

Vd: 4 L/kg (high)
ProteinBinding: 80-85% (primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes (rapid and extensive)

Elimination:

HalfLife: 20-27 hours (terminal half-life after patch removal, due to continued absorption from skin depot)
Clearance: 0.5 L/hr/kg
ExcretionRoute: Renal (75% as metabolites, <10% as unchanged drug), Fecal (9% as metabolites, <1% as unchanged drug)
Unchanged: <10% (renal), <1% (fecal)
âąī¸

Pharmacodynamics

OnsetOfAction: 6-12 hours (transdermal)
PeakEffect: 24-72 hours (transdermal)
DurationOfAction: Up to 72 hours (after patch application), effects may persist for 12-24 hours after patch removal due to skin depot.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

RISK OF ADDICTION, ABUSE, AND MISUSE; RISK EVALUATION AND MITIGATION STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL EXPOSURE; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYP3A4 INTERACTION; and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS. Fentanyl transdermal system is for use only in opioid-tolerant patients. Do not use in opioid non-tolerant patients. Life-threatening respiratory depression could occur at any dose in opioid non-tolerant patients.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy
+ Feeling weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or passing out
Feeling confused
Severe constipation or stomach pain, which may indicate a severe bowel problem
Trouble breathing, slow breathing, or shallow breathing
Noisy breathing
Breathing problems during sleep (sleep apnea)
Chest pain
Fast or slow heartbeat
Seizures
Depression
Trouble controlling body movements
Swelling in the arms or legs
Change in eyesight

Serotonin Syndrome: A Potentially Life-Threatening Condition

If you take this medication with certain other drugs, you may be at risk for a severe and potentially deadly condition called serotonin syndrome. Seek medical help immediately if you experience:

Agitation
Change in balance
Confusion
Hallucinations
Fever
Fast or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Sweating a lot
Severe diarrhea
Upset stomach
Throwing up
Severe headache

Adrenal Gland Problem: A Rare but Serious Condition

Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. Contact your doctor right away if you experience:

Feeling very tired or weak
Passing out
Severe dizziness
Very upset stomach
Throwing up
Decreased appetite

Other Possible Side Effects

Like all medications, this drug may cause side effects in some people. While many individuals may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:

Feeling dizzy, sleepy, tired, or weak
Dry mouth
Constipation
Diarrhea
Stomach pain
Upset stomach
Throwing up
Decreased appetite
Headache
Feeling cold
Trouble sleeping
Sweating a lot
* Irritation where the medication was administered

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow or shallow breathing
  • Extreme drowsiness or difficulty waking up
  • Dizziness or lightheadedness
  • Confusion
  • Pinpoint pupils
  • Cold, clammy skin
  • Blue lips or fingernails
  • Severe constipation or difficulty urinating
  • Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as:
+ Respiratory problems, including asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel blockage or narrowing
Kidney or liver disease
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
* Current use of certain medications, such as buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine whether it is safe to take this medication with your existing treatments and health status. Never start, stop, or adjust the dosage of any medication without consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying down position. Be cautious when climbing stairs.

Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses may be required to achieve the same effect. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not take more than the prescribed dose.

Additionally, regular use of opioid medications like this one can cause dependence. Suddenly stopping or reducing the dose may increase the risk of withdrawal or other severe problems. Consult your doctor before changing your dose or stopping the medication, and follow their instructions carefully. Monitor for signs of withdrawal, increased pain, mood changes, suicidal thoughts, or other adverse effects, and report them to your doctor.

Safe Use
Do not exceed the prescribed dose, frequency, or duration of treatment, as this may increase the risk of severe side effects. Avoid taking this medication with other strong pain medications or using a pain patch without consulting your doctor first.

If your pain worsens, you become more sensitive to pain, or you experience new pain, contact your doctor immediately. Do not take more than the prescribed dose.

Interactions and Contraindications
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Do not take this medication with alcohol or products containing alcohol, as this can cause unsafe and potentially fatal effects.

Seizure Risk
This medication may increase the risk of seizures, particularly in individuals with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.

Hormonal Effects
Long-term use of opioid medications may lead to decreased sex hormone levels. If you experience a decrease in libido, fertility problems, irregular menstrual periods, or ejaculation difficulties, contact your doctor.

MRI Precautions
The patch may contain metal, so remove it before undergoing an MRI.

Special Populations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Breastfeeding
Inform your doctor if you are breastfeeding, as this medication passes into breast milk and may harm your baby. Seek medical attention immediately if your baby appears excessively sleepy, limp, or has breathing difficulties.
🆘

Overdose Information

Overdose Symptoms:

  • Slowed or stopped breathing (respiratory depression)
  • Extreme drowsiness, inability to wake up
  • Pinpoint pupils
  • Limp muscles
  • Cold, clammy skin
  • Blue discoloration of lips or fingernails
  • Severely decreased heart rate and blood pressure
  • Coma

What to Do:

IMMEDIATELY call 911 or emergency services. Administer naloxone if available and trained to do so. Stay with the person until help arrives. Provide rescue breathing if necessary. Call 1-800-222-1222 (Poison Control Center).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • CYP3A4 inhibitors (strong, e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, nefazodone, nelfinavir, saquinavir, troleandomycin, voriconazole)
  • Benzodiazepines and other CNS depressants (unless benefits outweigh risks and patient is closely monitored)
  • Alcohol
  • Monoamine Oxidase Inhibitors (MAOIs) (within 14 days)
🔴

Major Interactions

  • Other CNS depressants (e.g., sedatives, hypnotics, anxiolytics, general anesthetics, phenothiazines, skeletal muscle relaxants, other opioids, gabapentinoids): Increased risk of respiratory depression, profound sedation, coma, and death.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol): Risk of serotonin syndrome.
  • Mixed agonist/antagonist opioids (e.g., buprenorphine, nalbuphine, pentazocine): May precipitate withdrawal symptoms or reduce analgesic effect.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): May decrease fentanyl plasma concentrations, leading to reduced efficacy and potential withdrawal.
🟡

Moderate Interactions

  • Anticholinergic drugs: Increased risk of urinary retention and/or severe constipation.
  • Diuretics: Opioids may reduce the efficacy of diuretics by inducing the release of antidiuretic hormone.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pain assessment (intensity, character, location)

Rationale: To establish baseline pain level and guide initial dosing/titration.

Timing: Prior to initiation of therapy

Respiratory rate and depth

Rationale: To assess baseline respiratory function and identify risk factors for respiratory depression.

Timing: Prior to initiation of therapy

Level of consciousness/sedation

Rationale: To assess baseline mental status and identify risk factors for excessive sedation.

Timing: Prior to initiation of therapy

Opioid tolerance status

Rationale: Fentanyl transdermal is only for opioid-tolerant patients. Verify prior opioid use and equivalent daily dose.

Timing: Prior to initiation of therapy

Concomitant medications (especially CNS depressants, CYP3A4 inhibitors/inducers)

Rationale: To identify potential drug interactions that increase risk of adverse effects.

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Pain assessment

Frequency: Regularly, especially during titration and with dose changes (e.g., daily for first few days, then weekly/monthly)

Target: Acceptable pain control with minimal side effects

Action Threshold: Uncontrolled pain (consider dose increase or alternative), excessive pain relief (consider dose decrease)

Respiratory rate and depth

Frequency: Frequently during initiation and titration (e.g., every 2-4 hours for first 24 hours after patch application, then daily or as clinically indicated)

Target: Normal for patient (e.g., 12-20 breaths/min)

Action Threshold: <10 breaths/min, shallow breathing, signs of hypoventilation (administer naloxone, provide respiratory support)

Level of consciousness/sedation

Frequency: Frequently during initiation and titration (e.g., every 2-4 hours for first 24 hours after patch application, then daily or as clinically indicated)

Target: Alert and oriented, or easily arousable

Action Threshold: Excessive sedation (e.g., difficult to arouse, somnolence, stupor) (consider dose reduction, naloxone)

Signs of opioid toxicity (e.g., miosis, constipation, nausea, vomiting, pruritus)

Frequency: Daily or as clinically indicated

Target: Minimal to no symptoms

Action Threshold: Persistent or worsening symptoms (consider dose reduction, symptomatic treatment)

Patch adhesion and skin integrity at application site

Frequency: With each patch change

Target: Patch fully adhered, no significant skin irritation

Action Threshold: Poor adhesion (reapply or use new patch), severe irritation (change site, consider alternative)

đŸ‘ī¸

Symptom Monitoring

  • Respiratory depression (slow, shallow breathing, cyanosis)
  • Excessive sedation/somnolence
  • Dizziness, lightheadedness
  • Nausea, vomiting
  • Constipation
  • Pruritus (itching)
  • Confusion, disorientation
  • Miosis (pinpoint pupils)
  • Signs of opioid withdrawal (if abruptly discontinued or dose reduced too quickly)
  • Signs of serotonin syndrome (agitation, hallucinations, tachycardia, fever, sweating, muscle rigidity, tremor, incoordination, nausea, vomiting, diarrhea)

Special Patient Groups

🤰

Pregnancy

Use during pregnancy is generally not recommended unless the potential benefit justifies the potential risk to the fetus. Prolonged use during pregnancy can result in neonatal opioid withdrawal syndrome (NOWS), which may be life-threatening if not recognized and treated.

Trimester-Specific Risks:

First Trimester: Potential for congenital malformations (limited data, but generally avoided).
Second Trimester: Risk of fetal growth restriction and other adverse outcomes.
Third Trimester: High risk of neonatal opioid withdrawal syndrome (NOWS) in the newborn, characterized by irritability, hyperactivity, abnormal sleep patterns, high-pitched cry, tremor, vomiting, diarrhea, and poor feeding. Risk of respiratory depression in the neonate if used close to delivery.
🤱

Lactation

Fentanyl is excreted into breast milk. Breastfeeding is generally not recommended while using fentanyl transdermal due to the risk of serious adverse reactions in the infant, including sedation, respiratory depression, and death. If breastfeeding is considered essential, monitor the infant closely for signs of sedation and respiratory depression.

Infant Risk: L3 (Moderate risk) - Risk of sedation, respiratory depression, poor feeding, and developmental delay in the infant. Monitor for signs of opioid effects.
đŸ‘ļ

Pediatric Use

Contraindicated in children under 2 years of age. For children 2 years and older, only for opioid-tolerant patients with chronic severe pain, and only if the child weighs at least 30 kg. Extreme caution and careful dose titration are required due to increased risk of respiratory depression, especially in smaller children or those not truly opioid-tolerant.

👴

Geriatric Use

Use with caution. Elderly patients may be more sensitive to the effects of fentanyl, particularly respiratory depression, due to decreased hepatic and renal function, and reduced lean body mass. Start with lower doses and titrate slowly. Monitor closely for adverse effects.

Clinical Information

💎

Clinical Pearls

  • Fentanyl transdermal is for chronic, severe pain in opioid-tolerant patients only. It is NOT for acute pain, post-operative pain, or opioid-naive patients due to the risk of fatal respiratory depression.
  • Ensure proper patient selection and thorough opioid conversion calculations to avoid overdose or under-dosing.
  • Educate patients and caregivers extensively on proper patch application, removal, and disposal (fold adhesive sides together and flush down toilet or use drug take-back program).
  • Emphasize the danger of heat exposure to the patch, which can significantly increase fentanyl absorption.
  • Always have naloxone readily available for patients prescribed fentanyl transdermal, and educate patients/caregivers on its use.
  • Monitor for signs of respiratory depression and excessive sedation, especially during initiation and dose titration.
  • Be aware of the prolonged half-life due to the skin depot; effects can persist for hours after patch removal.
  • Consider the potential for drug accumulation in patients with hepatic or renal impairment.
  • Counsel patients on the risks of addiction, abuse, and misuse, and the importance of safe storage.
🔄

Alternative Therapies

  • Other long-acting opioid analgesics (e.g., extended-release oxycodone, extended-release morphine, methadone, extended-release hydromorphone)
  • Non-opioid analgesics (e.g., NSAIDs, acetaminophen, gabapentinoids, tricyclic antidepressants) for neuropathic pain components
  • Interventional pain management techniques (e.g., nerve blocks, spinal cord stimulation)
  • Physical therapy, occupational therapy, psychological therapies (e.g., CBT) for chronic pain management
💰

Cost & Coverage

Average Cost: $200 - $600+ per 5 patches (75 mcg/hr)
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (often requires prior authorization and/or step therapy due to high abuse potential and cost)
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe use, do not share your medication with others, and never take someone else's medication.

This medication is accompanied by a Medication Guide, which provides crucial information about its use. It is essential to read this guide carefully and review it again each time your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider for clarification.

In the event of an overdose, a medication called naloxone can be used as part of the treatment. Discuss obtaining and using naloxone with your doctor or pharmacist. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. When seeking help, be prepared to provide information about what was taken, the amount, and the time it happened.

In case of a suspected overdose, contact your local poison control center or seek emergency medical care right away. Be prepared to provide details about the medication, including the dose and timing of the overdose, to ensure you receive appropriate treatment.